Goldman Sachs analysts led by Steven Kron share the firm's latest conviction list, which includes 23 of the bank's top picks ...

The housing market remains constrained in 2025. Goldman said mortgage rates will stay elevated, raising its year-end target ...

Fintel reports that on June 6, 2025, Goldman Sachs initiated coverage of Teva Pharmaceutical Industries Limited - Depositary ...

Goldman Sachs has added these three stocks to its Conviction List. They all have at least 20% upside potential to the analyst ...

Goldman Sachs has reined in risk-taking due to market volatility triggered by Donald Trump’s trade war and fears that rising ...

Goldman Sachs has moderated its risk-taking since U.S. President Donald Trump's April tariff announcement, and the Wall ...

Solomon reportedly lashed out at critics, confronted departing executives with yelling fits and probed suspected leakers to ...

Jubilant Bhartia Group received $600 million from Goldman Sachs to acquire a 40 per cent stake in Coca-Cola's Indian bottling ...

Goldman Sachs initiated coverage on U.S.-listed generic pharmaceutical companies with Buy ratings on Teva Pharmaceutical Industries (NYSE:TEVA) and Amneal Pharmaceuticals (NASDAQ:AMRX), and a Neutral ...

James Reynolds, global co-head of private credit at Goldman Sachs Asset Management discusses the state of private credit and ...

Goldman Sachs lowered Tesla's target price citing weak deliveries in Europe and US. Tesla stock fell 14% on Thursday, wiping ...